Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lupin Ltd Capital/Financing Update 2021

Mar 25, 2021

61031_rns_2021-03-25_a12b488f-e733-44b7-adb9-64a7e676e054.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

March 25, 2021

To.

~nal Stock Exchange of India ltd. Exchange Plaza, 5th Floor, Plot No. C/ 1, G Block, Bandra Kurio Complex, Bandra (East), Mumbai - 400 051 . Fax No.: 022-26598237/38/26598347

BSE ltd. Market Operations Dept. P. J. Towers, Dalal Street, Mumbai - 400 001. Tel : 022-22721233/4 Fax No 022-22723121

Dear Sir/ Madam,

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

This is to inform you that Lupin Limited has agreed in principle to subscribe to a partnership interest in ABCD Technologies LLP (to be renamed as lndoHealth Services LLP).

The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Clause A ( 1) of Port A, Schedule Ill of the aforesaid Regulations, is attached as per 'Annexure A'.

This is for your information and record.

Thanking you,

Yours faithfully,

R. V. SATAM (COMPANY SECRETARY) ACS- 11973

Encl.: - Annexure A

LUPIN LIMITED

Registered Office: 3'" Floor, Kalpataru Inspire, Off W. E. Highway, Santacruz (East). Mumba1 - 400 055 India. Tel : (91-22) 6640 2323. Corporate Identity Number: L241 OOMH1983PLC029442 www.lupin.com

Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 under Clouse A(1) of Port A, Schedule Ill of the aforesaid regulations on subscription of partnership interest in ABCD Technologies LLP (to be renamed as lndoHeolth Services LLP) by the Company.

a) Nome of the target entity, details in brief such
as size. turnover etc.:
i) Name of the Target entity: ABCD Technologies LLP (to be
renamed
hereinafter
lndoHeolth
Services
LLP),
OS
referred to as the Target entity.
ii) Details of Target entity: The Target entity is a recently
incorporated limited liability partnership (
) and has
LLP1
1
not commenced any business activities.
b) Whether the acquisition would fall within
related party tronsoction(s) and whether the
promoter/ promoter group/group companies
hove any interest in the entity being acquired?
If yes, nature of interest and details thereof
and whether the some is done at "Arms
length";
No.
c) Industry to which the entity being acquired
belongs;
Healthcore services.
d) Objects and effects of acquisition (including
but not limited to, disclosure of reasons for
acquisition of target entity, if its business is
outside the main line of business of the listed
entity;
with
objective
to
healthcore
Initiative
on
digitize
infrastructure in Indio towards facilitating Good Distribution
Practices inter olio, in support of the Notional Digital Health
Mission of Government of India (I Business I).
e) Brief details of any governmental or regulatory
approvals required for the acquisition;
None.
Indicative time period for completion of the
f)
acquisition;
On or before March 31, 2021 .
g) Nature of consideration -
whether cash
consideration or share swap and details of the
some;
Cash infusion as capital contribution.
h) Cost of acquisition or the price at which the
shores ore acquired;
INR 40 crores.
i) Percentage of shoreholding/control acquired
and/or number of shores acquired;
Up to 20% share of profit/loss in the Target entity.
j) Brief background about the entity acquired in
terms of products/line of business acquired,
dote of incorporation, history of lost 3 years
turnover, country in which the acquired entity
and
has
presence
any other significant
information (in brief);
The Target entity has been incorporated on l01h February,
2021.
The Target entity is o newly incorporated limited liability
LLP'), and has not commenced any business
partnership (
1
activities.
The Target entity through one or more LLPs and investments/
subsidiaries would engage in the above-mentioned Business.
-
~~
;fjll~
There ore other leading pharmaceutical companies who
would be joining the LLP. The proposed structure would
transparent and effective competition to the
ensure
benefit of patients in India.
~~~
.~
~

LUPIN LIMITED

Registered Office: 3'" Floor, Kalpataru Inspire. Off W. E. Highway, Santacruz (East), Mumbai - 400 055 India. Tel : (91-22) 6640 2323. Corporate Identity Number: L241 OOMH1 983PLC029442 www.lupin.com